Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"Rest easy"....LOL. Sure, those who sent money to MYDX two years ago thinking they were getting vape pens are "resting easy."
Try contacting MYDX and see what the estimate is for delivery....the silence will be deafening.
In case this is a serious question.....
Because the Securities and Exchange Act and Rule 144 require companies be current on their reports for at least 90 days in order to do such sales or transactions.
Further, companies don’t just call and offer money to buy another without digging deep. They sign NDAs and look at each others books... very closely. And the books would probably show some really dirty laundry not in the Ks or Qs (such as the default judgments and cases in active litigation).
And they sure as hell are going to want to know why the company sued Dewald and Sanzeri for $29M and came out with only a $5K settlement. Additionally, how much was spent to litigate that case and whether the company was required to reimburse Jerome Dewald for his legal expenses, and for how much. And how and why the company was forced to settle the $29M case for $5K to a defendant that, according to the court website, never had legal representation.
Further, companies are going to want to know where every single penny is spent, why and how. Same goes for every single share of the 4.64B+ OS right now.
Companies are going to ask why AeroDX, AquaDX OrganaDX have been talked about in interviews done by Yazbeck, in pump pieces, prospectus documents and in the financials dating back to 2015. Companies are going to want to know where things are with those and why after four years, they’re still “coming soon.”
Companies are going to want to know why MYDX spent at least $1M to market a product in China in 2017 that here in late 2019 still hasn’t been delivered to American customers.
Companies are going to want to know the details and see the paperwork for the Bright Light Marketing deals, the depth of the relationship with Harry Tajyar (someone who has been on the SEC’s radar for awhile now, and I believe has active complaint against him), and other people involved in 2016 and 2017 business dealings.
Companies are going to ask about the Phoenix debt and court cases in 2016 in Florida, they’re going to ask about the Section 3(a)(10) exemptions MYDX appears to believe they and exempt from in 2016 and 2017 and the details behind those people paid for “crisis communications.”
Companies are going to want to know why the vape pen has been “coming soon” since April 2017 and its progress. They’re going to ask much harder, pointed and detailed questions than read here.
Companies are going to want to know why MYDX said it would conduct Israeli Clinical Trials, produce results in Q3 2018, and why there are no results one year later.
Companies are going to want to know why the former MYDX Chief Medical Officer resigned after seven months. They’re going to want to know why she filed a counter-claim against the company. That’s active litigation, companies are not going to overlook that, they’re going to want to know if there’s truth and Yazbeck’s side of the story his side of the story when it comes to the serious accusations of him misrepresenting himself and spending funds outside of intended purposes of Jessica Peatross’ personal business.
Companies are going to want to know why MYDX paid so much to the Mr. Cannabis Group and for the first full quarter of their tenure only brought in $1,539 of Q1 2019 revenue. They’re going to want to know why there were total operating expenses of $495K to show for $1,539 in revenue.
They’re also going to want to know why over $145K in cash and shares was given to Erai Beckmann to consult, advise and promote a product (the pen) in 2018 that is still not available.
AND, they’re going to want to know why the Q1 2019 10-Q was filed late and why the company has yet to file its Q2 2019 financials.
Lastly, a company is going to want to know from Yazbeck what the value is in a company that has $12M in debt, a deficit of $40M and is on track for $6,156 of annual revenue.
So if Yazbeck can produce all that information, then why doesn’t he simply file the 10-Q? He has the information and denies Shareholders their right to know.
To emphasize the opening point, the company is delinquent in its financials, the most basic of requirements in order to be acquired.
That’s why.
But I was told MYDX can’t file a 10-Q because they have no CEO or CFO right now. So confusing.
Does that “clandestine activity” by MYDX include issuing a 10-Q any time soon that was due three weeks ago?
Tick tock.
The same source that claimed MYDX was going to be “scooped up” in an “all cash” transaction one month ago.
It IS a pump piece after all. Still, that last 10-Q looked really good.
Does anybody know how much this purchase was....in cash or shares? Not on attached PR or elsewhere.
Looks like the red sea won’t be parting after all.
That's not what the passage says.
What's the case number?
Besides, where IS the current MYDX 10-Q? The company hasn't filed one for Q2 2019 and is now delinquent.
And what is the name of that new alleged manufacturer?
MYDX found a new manufacturer.
Odd how no more MYDX "cheapies" are being "scooped up." Maybe those MYDX buys at .0185 or averaged in lower are figuring out how deep in the red those are.
IF MYDX paid the debt, it's probably under some "vendor" designation in the fins.
I don't think it was just the $10k + $325, as Plaintiff Rolla filed a memorandum with the court mentioning accrued interest nearly a year after the judgment against MYDX.
Yup...somebody really needed that $348 from the MYDX ATM today really bad.
When MYDX started selling its only available product, the OS was 22,081,928.
The MYDX TA report from Friday says the OS is now 4,648,547,212.
Some MYDX Shareholders are rather Salty about the MYDX OS increase of 20,951%
Strange, I don't see that case being active, it shows as dismissed in the court's website.
The only active case in civil division of the San Diego Court is the one where the former Chief Medical Officer of MYDX accuses then MYDX CEO Daniel Yazbeck of....
using money and other assets owned by DRJESS.COM to pay for costs and expenses incurred by businesses other than DRJESS.COM in which YAZBECK had an interest
refusing to pay vendors and suppliers amounts due and payable to such vendors for goods and services necessary for the profitable operation of DRJESS.COM
Or 100,000 MYDX shares to make that payment.
And with MYDX averaging over four million diluted shares per trading day in August, that’s a quick pay.
Unlike the manufacturing vendors that have sued MYDX for non-payment.
Huh? Who is this "forced seller?"
Or else what?
The company hasn’t even filed the applications for the clinical trials it said would have been complete Q3 2018.
New MYDX OS is 4,648,547,212, according to the new TA monthly report.
The monthly report says as of July 31st the MYDX OS was 4,541,510,157.
107,037,065 fresh MYDX shares printed in August, That’s an average of 4,865,321 shares diluted every trading day.
CTOs and 10-Qs are WAY different.
“Forced sellers”. LOL.....nah, it’s dilution.
MYDX was hauled to court (again) to pay ANOTHER manufacturer for past due bills.....
On October 18, 2018, ALL QUALITY & SERVICES, INC., a California corporation (“AQS”), filed a complaint (the “AQS Complaint”) in the Superior Court of California, County of Alameda against the Company alleging breach of contract relating to certain purchase orders and purchases related thereto. On February 14, 2019, the Company settled the matter with AQS by paying $25,000 cash to AQS and agreeing to pay a minimum of $15,000 each month until 2,000 units have been purchased from AQS which shall not be later than March 1, 2021.
New MYDX OS is 4,648,547,212, according to the new TA monthly report.
The monthly report says as of July 31st the MYDX OS was 4,541,510,157.
107,037,065 fresh MYDX shares printed in August, That’s an average of 4,865,321 shares diluted every trading day.
MYDX today:
- Delinquent, as it hasn’t filed a 10-Q.
- The vape pen has been “coming soon” since April 2017. Four official company deadlines have come and gone.
- The additional sensors, AeroDX, AquaDX and OrganaDX have been “coming soon” since 2015.
- The company said it would have results from an Israeli clinical trial in Q3 2018.
The company doesn’t own anything, it buys the license from a company called TRD.
Company doesn’t have enough shares to fulfill the TRD warrant (as spelled out in MYDX Q1 2019 10-Q....company is delinquent in Q2 2019 10-Q).
Tha application was filed in 2017. The last date in the Google patent application webpage is a dynamic date, just saying it’s the same status. It’s changes every day.
LOL, the MYDX Pen is not patented.
Not to mention that 3M cash sell at .00039. More dilution.
MYDelinquentX.
The link isn't dead, it was improperly embedded on this board.
Here is that link.
Alternatively, here is the pertinent text from the link...
Planet 13 Holdings
While Cresco Labs is working to get its pot products into hundreds of retail locations, Planet 13 Holdings (OTC:PLNHF) is opening its first store in the Golden State. But don't let that stop you from taking a look at its stock, because it's no ordinary store.
Planet 13's SuperStore in Las Vegas will span 112,000 square feet when completed. That's slightly bigger than the average Walmart. Beyond its massive size, Planet 13's SuperStore differentiates itself with a destination-type consumer experience. A sleek design; personalized service; and a huge selection of cannabis flowers, edibles, beverages, and concentrates have all proven popular with shoppers. In turn, Planet 13 has seen the number of people visiting its SuperStore and average spending per visitor rise sharply since it opened in November.
Planet 13 plans to bring this type of experience to California. In June, the company announced its intention to open a 40,000-square-foot cannabis store in Santa Ana. The new site is a 10-minute drive from Disneyland and only three miles from the South Coast Plaza mall, which hosts 24 million visitors a year.
If Planet 13 can replicate its Vegas-based SuperStore's success at this new location, investors who buy its stock today could be well rewarded.
All those damaging claims against MYDX PROVEN FALSE
A web page stating when MYDX filed patents and the most current event is a dynamic date setting?
So what’s the big deal here?
Correction: if those are CannaDX devices being shipped, only the liabilities from those shipments move to realized income.
The pen liability money won’t be realized because it hasn’t shipped, those remain liabilities.
And likely will be for a very long time, if not perpetuity.
And it’s both pen and CannaDX money, so all of it realized.
In addition to COGS and G&A, Yazbeck hasn’t collected any of his golden parachute yet. And you can be damn sure that’s going to be paid before any Salty MYDX Shareholders get their money.
2020 is more likely what MYDX got in Q2 2019 revenue. But we won’t know for sure until Yazbeck releases the delinquent 10-Q.